These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 21879778

  • 21. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
    Jones SC, Budnitz DS, Sorbello A, Mehta H.
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1099-106. PubMed ID: 23963962
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.
    Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S.
    Drug Saf; 2012 Jun 01; 35(6):447-57. PubMed ID: 22612850
    [Abstract] [Full Text] [Related]

  • 24. The safety profile of the fluoroquinolones.
    Bertino J, Fish D.
    Clin Ther; 2000 Jul 01; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [Abstract] [Full Text] [Related]

  • 25. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
    Becnel Boyd L, Maynard MJ, Morgan-Linnell SK, Horton LB, Sucgang R, Hamill RJ, Jimenez JR, Versalovic J, Steffen D, Zechiedrich L.
    Antimicrob Agents Chemother; 2009 Jan 01; 53(1):229-34. PubMed ID: 18838594
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data.
    Pisc J, Ting A, Skornicki M, Sinno O, Lee E.
    J Comp Eff Res; 2024 Jan 01; 13(1):e230108. PubMed ID: 38099519
    [Abstract] [Full Text] [Related]

  • 28. Safety profile of the fluoroquinolones: focus on levofloxacin.
    Liu HH.
    Drug Saf; 2010 May 01; 33(5):353-69. PubMed ID: 20397737
    [Abstract] [Full Text] [Related]

  • 29. Fluoroquinolone antibiotics block neuromuscular transmission.
    Sieb JP.
    Neurology; 1998 Mar 01; 50(3):804-7. PubMed ID: 9521283
    [Abstract] [Full Text] [Related]

  • 30. Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment.
    Perrot X, Bernard N, Vial C, Antoine JC, Laurent H, Vial T, Confavreux C, Vukusic S.
    Neurology; 2006 Dec 26; 67(12):2256-8. PubMed ID: 17065592
    [Abstract] [Full Text] [Related]

  • 31. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB.
    Curr Med Res Opin; 2007 Jun 26; 23(6):1403-13. PubMed ID: 17559736
    [Abstract] [Full Text] [Related]

  • 32. Exacerbation of myasthenia gravis after amoxicillin therapy: a case series.
    Vacchiano V, Solli P, Bartolomei I, Lai G, Liguori R, Salvi F.
    Neurol Sci; 2020 Aug 26; 41(8):2255-2257. PubMed ID: 32296986
    [Abstract] [Full Text] [Related]

  • 33. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
    Yarrington ME, Anderson DJ, Dodds Ashley E, Jones T, Davis A, Johnson M, Lokhnygina Y, Sexton DJ, Moehring RW.
    Infect Control Hosp Epidemiol; 2019 Nov 26; 40(11):1297-1300. PubMed ID: 31474240
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drug-induced neuromuscular blockade and myasthenia gravis.
    Barrons RW.
    Pharmacotherapy; 1997 Nov 26; 17(6):1220-32. PubMed ID: 9399604
    [Abstract] [Full Text] [Related]

  • 39. Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis.
    Gomez Rosado JO, Perez T, Fusco KN, Ahmed F, Nelson TL, Smith TA, Ma H, Barber T.
    Cureus; 2024 May 26; 16(5):e60186. PubMed ID: 38868287
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.